Source: Health Canada shortage reports · Updated Jul 9, 2026
Also sold as: Lidex, Lyderm, Topactin Emollient, Topactin
Some Fluocinonide products are in shortage in Canada (2 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A potent topical corticosteroid used to reduce inflammation and itching in skin conditions such as eczema and psoriasis.
Products affected
2 / 10
In shortage since
Jan 1, 2014
Reports on file
47
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TOPACTIN CREAM 0.05% U.S.P.
0.05% · CREAM · PALADIN LABS INC
DIN 00816132 · since Jan 1, 2014, no end estimate
Active shortage
TOPACTIN EMOLLIENT CREAM 0.05%
0.5MG · CREAM · PALADIN LABS INC
DIN 02240269 · since Jan 1, 2014, no end estimate
Discontinued
LIDEX
0.05% · CREAM · BAUSCH HEALTH, CANADA INC.
DIN 02161923
Resolved
LYDERM CREAM 0.05%
0.05% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 00716863 · ended May 5, 2023 · Disruption of the manufacture of the drug.
Resolved
LYDERM CREAM 0.05%
0.05% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 00716863 · ended Jan 6, 2023 · Disruption of the manufacture of the drug.
Resolved
TIAMOL CREAM 0.05%
0.05% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 00598933 · ended Nov 23, 2022 · Disruption of the manufacture of the drug.
Resolved
LYDERM CREAM 0.05%
0.05% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 00716863 · ended Nov 15, 2022 · Disruption of the manufacture of the drug.
Resolved
LIDEMOL
0.05% · CREAM · BAUSCH HEALTH, CANADA INC.
DIN 02163152 · ended Jul 1, 2021 · Registration of new API
Resolved
LIDEX
0.05% · GEL · BAUSCH HEALTH, CANADA INC.
DIN 02161974 · ended Jul 1, 2021 · Registration of new API
Resolved
LYDERM CREAM 0.05%
0.05% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 00716863 · ended Mar 4, 2021 · Disruption of the manufacture of the drug.
Resolved
LYDERM OINTMENT 0.05%
0.05% · OINTMENT · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 02236996 · ended Feb 15, 2021 · Disruption of the manufacture of the drug.
Resolved
LYDERM CREAM 0.05%
0.05% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 00716863 · ended Feb 10, 2021 · Disruption of the manufacture of the drug.
Showing 12 of 47 reports. All reports are on file with Health Canada.
What's happening
Fluocinonide is currently affected by 2 active shortage reports filed with Health Canada by PALADIN LABS INC.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Fluocinonide is classified under “CORTICOSTEROIDS, PLAIN” (ATC D07AC).
Recent changes
No changes recorded yet.
Common questions
What is Fluocinonide used for?
A potent topical corticosteroid used to reduce inflammation and itching in skin conditions such as eczema and psoriasis.
When will Fluocinonide be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Fluocinonide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.